29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Suppose you are in-house counsel for a construction company. Your Guaranteed Maximum Price (“GMP”...
Read More >
The Illinois legislature recently passed a law modifying the Contractor Prompt Payment Act, impactin...
Read More >
There have been an increasing number of reports that Immigration and Customs Enforcement (ICE) has b...
Read More >
I’m very outspoken, probably too much. Many people in the industry don’t like flamethrowers who ca...
Read More >
In an effort to update UK discrimination law, the Women and Equalities Committee of the UK Parliamen...
Read More >
Today USCIS implements its new public charge rule nationwide. The rule was previously enjoined in I...
Read More >